Business ❯ Pharmaceuticals

Corporate Strategy

Acquisitions Workforce Management Investment Decisions Mergers and Acquisitions Employment Divestment Job Cuts Talent Acquisition Merck Management Changes

Senior Source Says There Were No AstraZeneca‑Bristol Myers Merger Talks

The denial calmed markets yet left regulatory overlap and looming drug patent expiries as the main barriers to any large combination.

Pfizer CFO Dave Denton to Exit and Cecile Guegan Named Interim

GSK to Cut Up to 350 R&D Jobs in US and UK

U.S. Backs Bayer’s Bid for Supreme Court Review in Glyphosate Liability Fight

Merck to Buy Cidara for $9.2 Billion to Secure Long-Acting Flu Drug

Former FDA Biologics Chief Peter Marks Joins Eli Lilly to Lead Infectious Disease and Molecule Discovery

Novo Nordisk to Cut 9,000 Jobs, Lowers Profit Outlook in Global Restructuring

Novo Nordisk Cuts 9,000 Jobs as It Lowers 2025 Margin Outlook

CSL to Cut Up to 3,000 Jobs, Spin Off Seqirus in Sweeping Overhaul

EU Regulator Recommends AstraZeneca’s Low-Carbon COPD Inhaler

Bayer Proposes €8 Billion Capital Increase to Address Mounting Glyphosate Litigation

Sanofi Moves Forward with Sale of Doliprane Unit to American Fund CD&R

Pfizer Faces Activist Pressure as Ex-Execs Withdraw Support for Starboard